Renaissance Technologies - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 152 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.29 and the average weighting 0.5%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$979
-18.1%
730,400
+9.4%
0.00%0.0%
Q2 2023$1,195
-58.2%
667,400
-9.3%
0.00%
-50.0%
Q1 2023$2,862
+344.4%
735,700
+288.6%
0.00%
+300.0%
Q4 2022$644
-100.0%
189,300
-38.6%
0.00%
-50.0%
Q3 2022$1,683,000
-17.9%
308,300
-32.2%
0.00%0.0%
Q2 2022$2,051,000
+29.4%
454,800
+111.4%
0.00%0.0%
Q1 2022$1,585,000
+187.1%
215,100
+150.4%
0.00%
+100.0%
Q4 2021$552,000
-80.9%
85,900
-82.7%
0.00%
-75.0%
Q3 2021$2,883,000
+1409.4%
495,400
+2581.9%
0.00%
Q2 2021$191,000
-94.5%
18,472
-89.8%
0.00%
-100.0%
Q2 2020$3,443,000
-66.4%
181,800
-66.0%
0.00%
-70.0%
Q1 2020$10,258,000
+233.4%
534,000
+232.7%
0.01%
+400.0%
Q4 2019$3,077,000
+599.3%
160,500
+118.3%
0.00%
Q2 2019$440,000
-91.8%
73,515
-92.0%
0.00%
-100.0%
Q1 2019$5,366,000
+34.4%
918,800
+115.6%
0.01%
+25.0%
Q4 2018$3,994,000
+231.7%
426,253
+502.9%
0.00%
+300.0%
Q3 2018$1,204,000
-48.6%
70,700
-48.7%
0.00%0.0%
Q2 2018$2,343,000137,9000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders